Correlation Between 23Andme Holding and ProQR Therapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and ProQR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and ProQR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and ProQR Therapeutics BV, you can compare the effects of market volatilities on 23Andme Holding and ProQR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of ProQR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and ProQR Therapeutics.
Diversification Opportunities for 23Andme Holding and ProQR Therapeutics
-0.83 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between 23Andme and ProQR is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and ProQR Therapeutics BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProQR Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with ProQR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProQR Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and ProQR Therapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and ProQR Therapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the ProQR Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, 23Andme Holding Co is 1.25 times less risky than ProQR Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The ProQR Therapeutics BV is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 169.00 in ProQR Therapeutics BV on August 28, 2024 and sell it today you would earn a total of 185.00 from holding ProQR Therapeutics BV or generate 109.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. ProQR Therapeutics BV
Performance |
| Timeline |
| 23Andme Holding |
| ProQR Therapeutics |
23Andme Holding and ProQR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and ProQR Therapeutics
The main advantage of trading using opposite 23Andme Holding and ProQR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, ProQR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProQR Therapeutics will offset losses from the drop in ProQR Therapeutics' long position.| 23Andme Holding vs. Eliem Therapeutics | 23Andme Holding vs. HCW Biologics | 23Andme Holding vs. Scpharmaceuticals | 23Andme Holding vs. Milestone Pharmaceuticals |
| ProQR Therapeutics vs. Annexon | ProQR Therapeutics vs. Arrowhead Pharmaceuticals | ProQR Therapeutics vs. Day One Biopharmaceuticals | ProQR Therapeutics vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |